4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
7.79
-0.20 (-2.50%)
At close: Nov 22, 2024, 4:00 PM
7.78
-0.01 (-0.13%)
After-hours: Nov 22, 2024, 6:13 PM EST

4D Molecular Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
3608667197051,098-
Upgrade
Market Cap Growth
4.94%20.40%2.03%-35.79%--
Upgrade
Enterprise Value
-1665624974781,185-
Upgrade
Last Close Price
7.7920.2622.2121.9441.45-
Upgrade
PS Ratio
33046.5541.80229.9239.0980.68-
Upgrade
PB Ratio
0.732.813.112.214.28-
Upgrade
P/TBV Ratio
1.022.813.112.214.28-
Upgrade
EV/Sales Ratio
-27.10158.8826.5087.05-
Upgrade
Debt / Equity Ratio
0.040.050.070.05--
Upgrade
Asset Turnover
0.000.070.010.060.080.09
Upgrade
Quick Ratio
17.0315.2113.5815.2116.623.91
Upgrade
Current Ratio
17.3315.6514.0215.6916.884.05
Upgrade
Return on Equity (ROE)
-32.50%-37.40%-39.06%-24.78%-39.59%-93.56%
Upgrade
Return on Assets (ROA)
-21.80%-23.45%-22.35%-13.89%-20.44%-36.75%
Upgrade
Return on Capital (ROIC)
-22.81%-24.75%-23.59%-15.06%-24.73%-54.11%
Upgrade
Earnings Yield
-39.84%-11.64%-14.94%-10.11%-5.16%-
Upgrade
FCF Yield
-32.42%-9.07%-13.65%-11.10%-4.73%-
Upgrade
Buyback Yield / Dilution
-38.91%-20.95%-16.66%-331.23%-25.05%-1.85%
Upgrade
Total Shareholder Return
-38.91%-20.95%-16.66%-331.23%-25.05%-1.85%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.